Actas Dermo-Sifiliograficas
Published by Elsevier
ISSN : 0001-7310 eISSN : 1578-2190
Abbreviation : Actas Gr.
Aims & Scope
The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV).
Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain.
In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern.
All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style.
Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews.
Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.8 |
2024 | 3.80 |
Journal Rank
Year | Value |
---|---|
2024 | 13763 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 867 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.401 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,900.00 EUR. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas
Citation: 503
Authors: A., N., S., A.
-
Incidencia y mortalidad del cáncer cutáneo en España: revisión sistemática y metaanálisis
Citation: 144
Authors: A., M.A., M.M., C., L., I., R., I.
-
Lepra: puesta al dÃa. Definición, patogénesis, clasificación, diagnóstico y tratamiento
Citation: 128
Authors: K., S.E., J.C., J.
-
Obesidad y psoriasis: naturaleza inflamatoria de la obesidad, relación entre psoriasis y obesidad e implicaciones terapéuticas
Citation: 100
Authors: J.M., V., R.M., R., J.C., N., E.
-
Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento
Citation: 99
Authors: L., J.M., G., P., R.F., I., M., M., M., M., C., E., V., E., J.L. López, S.E., J.C., J., R., C., A., R., R., D.
-
Documento de consenso sobre la evaluación y el tratamiento de la psoriasis moderada/grave del Grupo Español de Psoriasis de la Academia Española de DermatologÃa y VenereologÃa
Citation: 99
Authors: L., X., J.M., E., C., J.M., J.L., J.C., J.L., F., H.
-
Prevalencia de la psoriasis en España en la era de los agentes biológicos
Citation: 87
Authors: C., J.M., M.
-
Progress in Understanding the Immunopathogenesis of Psoriasis
Citation: 82
Authors: R.K.H., C., F.O.